Harnessing the Power of All of Us for Autoimmune Disease Research
Date and Time
– March 24, 2025, 3:00 PM EDTVirtual Only.
Event Information
The purpose this session is to discuss how the All of Us dataset can be used to support autoimmune disease research, and highlight participants as partners and the broad accessibility of data for research purposes.
Target Audience: this session is designed for a broad audience with an interest in autoimmune disease research.
Speakers
 | Janine Austin Clayton, M.D., FARVO NIH Associate Director for Research on Women’s Health Director, NIH Office of Research on Women’s Health Janine Austin Clayton, M.D., FARVO, was appointed Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH) in 2012. Dr. Clayton has strengthened NIH support for research on diseases, disorders, and conditions that affect women. She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum, a part of NIH’s initiative to enhance reproducibility, rigor, and transparency. As co-chair of the NIH Working Group on Women in Biomedical Careers with the current NIH Director, Dr. Clayton also leads NIH’s efforts to advance women in science careers. |
 | Josh Denny, M.D., M.S. Chief Executive Officer NIH All of Us Research Program Josh Denny, M.D., M.S., is the Chief Executive Officer of the National Institutes of Health’s All of Us Research Program. All of Us seeks to enroll at least 1 million diverse participants to build an indispensable resource that accelerates precision medicine for all populations. Dr. Denny has been involved since the program’s inception. He was a member of the NIH Precision Medicine Initiative Working Group of the Advisory Committee to the Director, which developed the program’s initial scientific blueprint. He then led the program’s initial prototyping project and the All of Us Data and Research Center. Dr. Denny was named CEO of All of Us in January 2020. Before joining NIH, Dr. Denny was a practicing physician and held several leadership positions at Vanderbilt University Medical Center, including Professor of Biomedical Informatics and Medicine, founding Director of the Center for Precision Medicine, and Vice President for Personalized Medicine. At Vanderbilt, he led discovery and implementation projects in precision medicine, including clinical pharmacogenomics and Vanderbilt’s DNA biobank. He was a pioneer in the use of electronic health records for genomics studies, including the initial descriptions of phenome‐wide association studies and phenotype risk scores. |
 | Victoria Shanmugam, MBBS, MRCP, FACR, CCD Director NIH Office of Autoimmune Disease Research in the Office of Research on Women’s Health Vicki Shanmugam, MBBS, MRCP, FACR, CCD, is an experienced physician-scientist, rheumatologist, and academic leader. She graduated from Oxford University with a B.A. in physiology and completed her medical degree at Imperial College School of Medicine in London, graduating with honors in medicine. She is a member of the Royal College of Physicians in London. Dr. Shanmugam completed the Internal Medicine Residency and Rheumatology Fellowship at Georgetown University and joined the faculty of Georgetown University School of Medicine in 2007. She previously served as Director of Rheumatology at the George Washington University. She now serves as the Director of the NIH Office of Autoimmune Disease Research in the Office of Research on Women’s Health. |
Agenda
| Time | Session |
|---|---|
2:00–2:15 p.m. | Welcome and Opening Remarks
|
2:15–2:55 p.m. | All of Us Discussion and Question and Answer
|
| 2:55–3:00 p.m. | Closing Remarks |
Special Accommodations
Sign language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in this event should email OADRInfo@nih.gov. Requests should be made at least five business days in advance of the event.